Home LiteratureArticle Details
PMID: 12832554 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Increased depression-like behaviors in corticotropin-releasing factor receptor-2-deficient mice: sexually dichotomous responses.

Bale TL, Vale WW

Abstract

Depressive disorders affect nearly 19 million American adults, making depression and the susceptibility for developing depression a critical focus of mental health research today. Females are twice as likely to develop depression as males. Stress is a known risk factor for developing depression, and recent hypotheses suggest an involvement of an overactive stress axis. As mediators of the stress response, corticotropin-releasing factor (CRF) and its receptors (CRFR1 and CRFR2) have been implicated in the propensity for developing stress-related mood disorders. Mice deficient in CRFR2 display increased anxiety-like behaviors and a hypersensitive stress response. As a possible animal model of depression, these mice were tested for depression-like behaviors in the forced swim test. Comparisons were made between wild-type and mutant animals, as well as between sexes. Male and female CRFR2-mutant mice showed increased immobility as an indicator of depression compared with wild-type mice of the same sex. In addition, mutant and wild-type female mice demonstrated increased immobile time compared with males of the same genotype. Treatment of CRFR2-deficient mice with the CRFR1 antagonist antalarmin decreased immobile time and increased swim time in both sexes. We found a significant effect of sex for both time spent immobile and swimming after antalarmin treatment. Because differences in behaviors in the forced swim test are good indicators of serotonergic and catecholaminergic involvement, our results may reveal an interaction of CRF pathways with other known antidepressant systems and may also support an involvement of CRF receptors in the development of depression such that elevated CRFR1 activity, in the absence of CRFR2, increases depression-like behaviors.

MeSH Terms
Animals Behavior, Animal/drug effects Depression/drug therapy,genetics,physiopathology Disease Models, Animal Female Male Mice Mice, Neurologic Mutants Motor Activity/drug effects Pyrimidines/pharmacology Pyrroles/pharmacology Receptors, Corticotropin-Releasing Hormone/antagonists & inhibitors,deficiency,genetics Sex Factors Stress, Physiological/physiopathology Swimming
Chemicals
CRF receptor type 2 Pyrimidines Pyrroles Receptors, Corticotropin-Releasing Hormone antalarmin CRF receptor type 1
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Bale Tracy L
Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, California 92037, USA. [email protected]
Vale Wylie W
References (43)
43 references, click to expand
  1. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety.
    J Psychiatr Res. 1999 May-Jun;33(3):181-214 PMID: 10367986
  2. The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders.
    Biol Psychiatry. 1999 Dec 1;46(11):1509-22 PMID: 10599479
  3. Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus.
    Neuropsychopharmacology. 2000 Feb;22(2):148-62 PMID: 10649828
  4. The role of afferents to the locus coeruleus in the handling stress-induced increase in the release of noradrenaline in the medial prefrontal cortex: a dual-probe microdialysis study in the rat brain.
    Eur J Pharmacol. 2000 Jan 17;387(3):279-86 PMID: 10650173
  5. Gender differences in depression and antidepressant pharmacokinetics and adverse events.
    Ann Pharmacother. 2000 Jan;34(1):80-8 PMID: 10669189
  6. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2.
    Nat Genet. 2000 Apr;24(4):403-9 PMID: 10742107
  7. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.
    Nat Genet. 2000 Apr;24(4):410-4 PMID: 10742108
  8. Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2.
    Nat Genet. 2000 Apr;24(4):415-9 PMID: 10742109
  9. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates.
    Proc Natl Acad Sci U S A. 2000 May 23;97(11):6079-84 PMID: 10823952
  10. Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated.
    J Psychiatr Res. 2000 May-Jun;34(3):171-81 PMID: 10867111
  11. Sex differences and the HPA axis: implications for psychiatric disease.
    J Gend Specif Med. 1998 Sep;1(1):21-7 PMID: 11279849
  12. Gender differences in the genetic epidemiology of major depression.
    J Gend Specif Med. 1998 Oct-Nov;1(2):28-31 PMID: 11281009
  13. Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor.
    J Neurosci. 2001 Apr 15;21(8):2833-41 PMID: 11306635
  14. The role of functional neuroimaging in the neuropsychology of depression.
    J Clin Exp Neuropsychol. 2001 Feb;23(1):121-36 PMID: 11320448
  15. Evidence for regional heterogeneity in corticotropin-releasing factor interactions in the dorsal raphe nucleus.
    J Comp Neurol. 2001 Jul 9;435(4):450-63 PMID: 11406825
  16. Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic and noradrenergic neurons of the murine basal forebrain and brainstem nuclei--potential implication for arousal and attention.
    Neuroscience. 2001;104(3):643-52 PMID: 11440798
  17. Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior.
    J Neurosci. 2002 Jan 1;22(1):193-9 PMID: 11756502
  18. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression.
    Curr Opin Pharmacol. 2002 Feb;2(1):23-33 PMID: 11786305
  19. Corticotropin-releasing hormone receptor type 1-deficiency enhances hippocampal serotonergic neurotransmission: an in vivo microdialysis study in mutant mice.
    Neuroscience. 2002;109(2):253-66 PMID: 11801362
  20. The role of corticotropin-releasing hormone in the dorsal raphe nucleus in mediating the behavioral consequences of uncontrollable stress.
    J Neurosci. 2002 Feb 1;22(3):1020-6 PMID: 11826130
  21. 4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II. Characterization in rodent models of stress-related disorders.
    J Pharmacol Exp Ther. 2002 Apr;301(1):333-45 PMID: 11907191
  22. Neurobiology of depression.
    Neuron. 2002 Mar 28;34(1):13-25 PMID: 11931738
  23. Assessing antidepressant activity in rodents: recent developments and future needs.
    Trends Pharmacol Sci. 2002 May;23(5):238-45 PMID: 12008002
  24. Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide.
    Brain Res. 2002 Jul 5;943(1):142-50 PMID: 12088848
  25. Antagonism of corticotropin-releasing factor receptors in the locus coeruleus attenuates shock-induced freezing in rats.
    Brain Res. 1992 Aug 7;587(2):263-8 PMID: 1326376
  26. Corticotropin-releasing factor innervation of the locus coeruleus region: distribution of fibers and sources of input.
    Neuroscience. 1992;48(3):689-705 PMID: 1376457
  27. New vistas in neuropeptide research in neuropsychiatry: focus on corticotropin-releasing factor.
    Neuropsychopharmacology. 1992 Feb;6(2):69-75 PMID: 1610487
  28. Involvement of corticotropin-releasing factor in chronic stress regulation of the brain noradrenergic system.
    Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8382-6 PMID: 1681536
  29. Corticotropin-releasing factor: putative neurotransmitter in the noradrenergic nucleus locus ceruleus.
    Psychopharmacol Bull. 1989;25(3):306-11 PMID: 2576315
  30. The role of corticotropin-releasing factor in the pathogenesis of major depression.
    Pharmacopsychiatry. 1988 Mar;21(2):76-82 PMID: 3293091
  31. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.
    Science. 1981 Sep 18;213(4514):1394-7 PMID: 6267699
  32. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression.
    J Neurosci. 1995 Oct;15(10):6340-50 PMID: 7472399
  33. Corticotropin-releasing factor neurotransmission in locus coeruleus: a possible site of antidepressant action.
    Brain Res Bull. 1994;35(5-6):581-7 PMID: 7859115
  34. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior.
    J Neurosci. 1994 May;14(5 Pt 1):2579-84 PMID: 8182429
  35. Pharmacological comparison of two corticotropin-releasing factor antagonists: in vivo and in vitro studies.
    J Pharmacol Exp Ther. 1994 Jan;268(1):359-65 PMID: 8301577
  36. In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.
    Endocrinology. 1996 Dec;137(12):5747-50 PMID: 8940412
  37. Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity.
    J Pharmacol Exp Ther. 1997 Apr;281(1):163-72 PMID: 9103494
  38. Locus coeruleus activation by colon distention: role of corticotropin-releasing factor and excitatory amino acids.
    Brain Res. 1997 May 9;756(1-2):114-24 PMID: 9187321
  39. Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression.
    Exp Clin Psychopharmacol. 1997 May;5(2):107-12 PMID: 9234045
  40. Gender differences in depression: implications for treatment.
    J Clin Psychiatry. 1997;58 Suppl 15:12-8 PMID: 9427872
  41. Effects of corticotropin-releasing factor on brain serotonergic activity.
    Neuropsychopharmacology. 1998 Jun;18(6):492-502 PMID: 9571657
  42. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs.
    Behav Pharmacol. 1997 Nov;8(6-7):523-32 PMID: 9832966
  43. The role of corticotropin-releasing factor in depression and anxiety disorders.
    J Endocrinol. 1999 Jan;160(1):1-12 PMID: 9854171
Article Info
Journal
The Journal of neuroscience : the official journal of the Society for Neuroscience
Abbr.
J Neurosci
ISSN
1529-2401
Published
2003-06-15
Pages
5295-301
Language
English
Region
United States
NLM ID
8102140
PMCID
PMC6741155
Subset
IM
Grants
NIDDK NIH HHS · P01 DK026741 · United States
NIDDK NIH HHS · DK 26741 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]